Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

[Study on significance of multitargeted fluorescence in situ hybridization for urothelial carcinoma].

Xiao L, Yin YL, Zhu XZ, Chen Y, Lu C, Yu B.

Zhonghua Bing Li Xue Za Zhi. 2013 Jul;42(7):465-6. doi: 10.3760/cma.j.issn.0529-5807.2013.07.008. Chinese. No abstract available.

PMID:
24246866
2.

[Detection of urothelial carcinoma of the urinary bladder by multicolor fluorescence in situ hybridization].

Zhang YG, Bi XG, Han YL, Cai Y, Xu X, Wu YP, Yang YL, Ma JH, Zhao P, Jia XM, Wang MR.

Ai Zheng. 2007 Feb;26(2):189-93. Chinese.

PMID:
17298751
3.
4.

Chromosomal abnormalities in macroscopically normal urothelium in patients with bladder pT1 and pT2a urothelial carcinoma: a fluorescence in situ hybridization study and correlation with histologic features.

Mazzucchelli R, Barbisan F, Stramazzotti D, Montironi R, Lopez-Beltran A, Scarpelli M.

Anal Quant Cytol Histol. 2005 Jun;27(3):143-51.

PMID:
16121635
5.

Chromosome instability and progression in urothelial cell carcinoma of the bladder.

Santos L, Pereira S, Leite RP, Souto M, Amaro T, Criado B.

Acta Oncol. 2003;42(2):169-73.

PMID:
12801136
6.

Fluorescent in situ hybridization as a predictor of relapse in urothelial carcinoma.

García-Peláez B, Trias I, Román R, Pubill C, Banús JM, Puig X.

Actas Urol Esp. 2013 Jul-Aug;37(7):395-400. doi: 10.1016/j.acuro.2012.11.005. Epub 2013 Feb 27. English, Spanish.

PMID:
23453297
7.

DNA aberrations in urinary bladder cancer detected by flow cytometry and FISH.

Sauter G, Gasser TC, Moch H, Richter J, Jiang F, Albrecht R, Novotny H, Wagner U, Bubendorf L, Mihatsch MJ.

Urol Res. 1997;25 Suppl 1:S37-43.

PMID:
9079755
8.

[Molecular cytogenetic study of bladder transitional cell carcinoma by FISH].

Shou J, Wang M, Ma J.

Zhonghua Zhong Liu Za Zhi. 2000 Jan;22(1):36-8. Chinese.

PMID:
11776593
9.

Chromosomal aberrations in transitional cell carcinoma that are predictive of disease outcome are independent of polyploidy.

Bartlett JM, Adie L, Watters AD, Going JJ, Grigor KM.

BJU Int. 1999 Nov;84(7):775-9.

PMID:
10532970
10.

[Fluorescence in situ hybridization in diagnosis of urinary bladder cancer].

Stroganova AM, Khachaturian AV.

Arkh Patol. 2006 Sep-Oct;68(5):43-6. Russian.

PMID:
17144532
11.

Detection of genetic aberrations in bladder cancer using in situ hybridization.

Ramaekers FC, Hopman AH.

Ann N Y Acad Sci. 1993 Mar 20;677:199-213. Review. No abstract available.

PMID:
8098592
12.

Aberrations of chromosomes 9 and 17 in bilharzial bladder cancer as detected by fluorescence in situ hybridization.

Ghaleb AH, Pizzolo JG, Melamed MR.

Am J Clin Pathol. 1996 Aug;106(2):234-41.

PMID:
8712180
13.

Aneusomy of chromosomes 7 and 17 predicts the recurrence of transitional cell carcinoma of the urinary bladder.

Watters AD, Ballantyne SA, Going JJ, Grigor KM, Bartlett JM.

BJU Int. 2000 Jan;85(1):42-7.

14.

Molecular cytogenetic analysis of urothelial carcinomas using urine samples.

Ayati M, Tousi VN, Sabokba T, Vaziri-Nasab H, Mehrkhani F, Jamshidian H, Dastan J, Mosavi-Jarrahi AR, Ghaffari SR.

Asian Pac J Cancer Prev. 2008 Oct-Dec;9(4):687-90.

15.

Does topical instillation therapy influence chromosomal aberrations in superficial bladder cancer?

Pycha A, Mian C, Hofbauer J, Haitel A, Wiener H, Marberger M.

J Urol. 1998 Jan;159(1):265-9.

PMID:
9400492
16.

DNA flow cytometric analysis and numerical chromosome 9 aberrations detected by interphase cytogenetics in superficial bladder TCC.

Eleuteri P, Grollino MG, Pomponi D, Calugi G, Rocchi M, De Vita R.

Eur J Histochem. 1997;41 Suppl 2:161-2. No abstract available.

PMID:
9859830
17.

Distinguishing urothelial carcinoma in the upper urinary tract from benign diseases with hematuria using FISH.

Wang J, Wu J, Peng L, Tu P, Li W, Liu L, Cheng W, Wang X, Zhou S, Shi S, Ma H, Lu G, Zhou X.

Acta Cytol. 2012;56(5):533-8. doi: 10.1159/000341622. Epub 2012 Sep 27.

PMID:
23075895
18.

[Ki-67 fraction, p53 alteration and numerical chromosome aberrations (chromosomes 7 and 17) in formalin fixed bladder tumors].

Moch H, Sauter G, Gudat F, Waldman F, Mihatsch MJ.

Verh Dtsch Ges Pathol. 1993;77:226-30. German.

PMID:
7511286
19.

Bladder irrigation specimens assayed by fluorescence in situ hybridization to interphase nuclei.

Wheeless LL, Reeder JE, Han R, O'Connell MJ, Frank IN, Cockett AT, Hopman AH.

Cytometry. 1994 Dec 1;17(4):319-26.

20.

UroVysion compared with cytology and quantitative cytology in the surveillance of non-muscle-invasive bladder cancer.

Moonen PM, Merkx GF, Peelen P, Karthaus HF, Smeets DF, Witjes JA.

Eur Urol. 2007 May;51(5):1275-80; discussion 1280. Epub 2006 Oct 30.

PMID:
17084511

Supplemental Content

Support Center